Drug Shortage Report for POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP

Last updated on 2023-09-05 History
Report ID 166363
Drug Identification Number 00037869
Brand name POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP
Common or Proper name POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) POTASSIUM CHLORIDE
Strength(s) 149MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 20ml vial
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-10-18
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2023-09-05
Company comments 10mL format remains available.
Health Canada comments
Tier 3 Status Yes
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2023-09-05 English Compare
v12 2023-08-01 French Compare
v11 2023-08-01 English Compare
v10 2023-04-04 French Compare
v9 2023-04-04 English Compare
v8 2022-10-19 English Compare
v7 2022-10-18 French Compare
v6 2022-10-18 English Compare
v5 2022-10-16 English Compare
v4 2022-08-25 French Compare
v3 2022-08-25 English Compare
v2 2022-08-08 French Compare
v1 2022-08-08 English Compare

Showing 1 to 13 of 13